KR20030055442A - Stabilized enzyme producing method using a polymer and a composition contained these enzyme - Google Patents
Stabilized enzyme producing method using a polymer and a composition contained these enzyme Download PDFInfo
- Publication number
- KR20030055442A KR20030055442A KR1020010084980A KR20010084980A KR20030055442A KR 20030055442 A KR20030055442 A KR 20030055442A KR 1020010084980 A KR1020010084980 A KR 1020010084980A KR 20010084980 A KR20010084980 A KR 20010084980A KR 20030055442 A KR20030055442 A KR 20030055442A
- Authority
- KR
- South Korea
- Prior art keywords
- enzyme
- polysaccharide
- stabilizing
- polysaccharides
- stabilized
- Prior art date
Links
- 102000004190 Enzymes Human genes 0.000 title claims abstract description 145
- 108090000790 Enzymes Proteins 0.000 title claims abstract description 145
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 238000000034 method Methods 0.000 title claims description 22
- 229920000642 polymer Polymers 0.000 title description 2
- 229940088598 enzyme Drugs 0.000 claims abstract description 140
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 55
- 239000005017 polysaccharide Substances 0.000 claims abstract description 55
- 150000004676 glycans Chemical class 0.000 claims abstract description 53
- 230000000087 stabilizing effect Effects 0.000 claims abstract description 33
- 239000002537 cosmetic Substances 0.000 claims abstract description 29
- 239000004365 Protease Substances 0.000 claims abstract description 24
- 108010014251 Muramidase Proteins 0.000 claims abstract description 15
- 102000016943 Muramidase Human genes 0.000 claims abstract description 15
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims abstract description 15
- 229960000274 lysozyme Drugs 0.000 claims abstract description 14
- 239000004325 lysozyme Substances 0.000 claims abstract description 14
- 235000010335 lysozyme Nutrition 0.000 claims abstract description 14
- 108010059892 Cellulase Proteins 0.000 claims abstract description 13
- 108090000526 Papain Proteins 0.000 claims abstract description 13
- 229940106157 cellulase Drugs 0.000 claims abstract description 13
- 229940055729 papain Drugs 0.000 claims abstract description 13
- 235000019834 papain Nutrition 0.000 claims abstract description 13
- 229920001285 xanthan gum Polymers 0.000 claims abstract description 11
- 239000000230 xanthan gum Substances 0.000 claims abstract description 10
- 235000010493 xanthan gum Nutrition 0.000 claims abstract description 10
- 229940082509 xanthan gum Drugs 0.000 claims abstract description 10
- 108010004032 Bromelains Proteins 0.000 claims abstract description 9
- 235000019835 bromelain Nutrition 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 8
- 244000007835 Cyamopsis tetragonoloba Species 0.000 claims abstract 2
- 230000001590 oxidative effect Effects 0.000 claims abstract 2
- 241000872931 Myoporum sandwicense Species 0.000 claims description 8
- 230000006641 stabilisation Effects 0.000 claims description 5
- 238000011105 stabilization Methods 0.000 claims description 5
- 235000020510 functional beverage Nutrition 0.000 claims description 3
- 230000000069 prophylactic effect Effects 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 239000008393 encapsulating agent Substances 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 abstract description 7
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 abstract description 6
- 229940072056 alginate Drugs 0.000 abstract description 6
- 229920000615 alginic acid Polymers 0.000 abstract description 6
- 235000010443 alginic acid Nutrition 0.000 abstract description 6
- 150000001720 carbohydrates Chemical class 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 20
- 238000009472 formulation Methods 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 11
- 244000005700 microbiome Species 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- 206010040844 Skin exfoliation Diseases 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000012360 testing method Methods 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 7
- 229920002907 Guar gum Polymers 0.000 description 6
- 239000000665 guar gum Substances 0.000 description 6
- 235000010417 guar gum Nutrition 0.000 description 6
- 229960002154 guar gum Drugs 0.000 description 6
- 238000001962 electrophoresis Methods 0.000 description 5
- 238000004299 exfoliation Methods 0.000 description 5
- 241000186427 Cutibacterium acnes Species 0.000 description 4
- 102000011782 Keratins Human genes 0.000 description 4
- 108010076876 Keratins Proteins 0.000 description 4
- 241000191967 Staphylococcus aureus Species 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 229940120503 dihydroxyacetone Drugs 0.000 description 4
- 229940055019 propionibacterium acne Drugs 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- 210000002421 cell wall Anatomy 0.000 description 3
- 239000007979 citrate buffer Substances 0.000 description 3
- 238000005538 encapsulation Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000007613 environmental effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 238000003860 storage Methods 0.000 description 3
- 244000303965 Cyamopsis psoralioides Species 0.000 description 2
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DEOKFPFLXFNAON-UHFFFAOYSA-N N-α-Benzoyl-DL-arginine 4-nitroanilide hydrochloride Chemical compound Cl.C=1C=C([N+]([O-])=O)C=CC=1NC(=O)C(CCCN=C(N)N)NC(=O)C1=CC=CC=C1 DEOKFPFLXFNAON-UHFFFAOYSA-N 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical class NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 235000019419 proteases Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
- WDMUXYQIMRDWRC-UHFFFAOYSA-N 2-hydroxy-3,4-dinitrobenzoic acid Chemical compound OC(=O)C1=CC=C([N+]([O-])=O)C([N+]([O-])=O)=C1O WDMUXYQIMRDWRC-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical group C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001917 Ficoll Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920001503 Glucan Polymers 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 125000003047 N-acetyl group Chemical group 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 239000012722 SDS sample buffer Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- UDSAIICHUKSCKT-UHFFFAOYSA-N bromophenol blue Chemical compound C1=C(Br)C(O)=C(Br)C=C1C1(C=2C=C(Br)C(O)=C(Br)C=2)C2=CC=CC=C2S(=O)(=O)O1 UDSAIICHUKSCKT-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- LVQSCKUKDKAQGO-UHFFFAOYSA-L disodium;diiodide Chemical compound [Na+].[Na+].[I-].[I-] LVQSCKUKDKAQGO-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000002101 lytic effect Effects 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/66—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 다당체를 이용한 안정화 효소의 제조방법 및 이들 안정화 효소가 첨가된 조성물에 관한 것으로, 보다 자세하게는 크산탄 검, 구아 검, 알지네이트를 이용하여 효소를 엔트랩핑(entrapping)하여 효소의 환경적 및 화학적인 인자에 인한 변화를 방지하고, 또한 이에 생산된 효소 단백질을 화장료 등에 적용하여 사용하는 것에 관한 것이다.The present invention relates to a method for preparing a stabilizing enzyme using a polysaccharide and to a composition to which these stabilizing enzymes are added, and more particularly, to entrap the enzyme using xanthan gum, guar gum, and alginate to enzymatically protect the environmental and Prevents changes due to chemical factors, and also relates to the use of the enzyme protein produced therein applied to cosmetics and the like.
종래, 화장품에는 그 사용 목적에 따라 각종 효소를 첨가·사용하여 왔는데, 예를 들어 파파인(papain) 및 브로멜라인(bromelain), 라이소자임(lysozyme) 그리고 셀루라제(cellulase)의 공통된 피부 각질 제거능과 함께 브로멜라인은 항염증제(anti-inflammatory agent)의 기능을 갖고 있어 피부개선효과를 기대할 수 있으며, 라이소자임과 셀루라제는 세균의 세포벽을 파괴하여 미생물오염을 막아주며, 피부에 존재하는 유해 미생물(Staphylococcus aureus, Propionibacterium acnes)들의 생육을 제어할 수 있다.Conventionally, cosmetics have been added with various enzymes according to their purpose of use, for example, with the common skin exfoliation ability of papain, bromelain, lysozyme and cellulase. Bromelain has the function of anti-inflammatory agent, so it can be expected to improve the skin. Lysozyme and cellulase destroy microbial contamination by destroying the cell wall of bacteria, and harmful microorganisms ( Staphylococcus aureus) on the skin , Propionibacterium acnes ) can control the growth.
그런데, 상기와 같은 목적으로 화장품에 첨가되는 효소는 단백질로 구성되어 있어 온도, 화학물질 등에 의해 쉽게 분해·변성되어 활성을 잃어버리는 등 그 안정성이 극히 낮아 이용에 곤란한 점이 있다. 따라서, 화장품 조성성분, 화장품의 보관·유통온도 등의 각종 주변요인은 효소의 안정성을 저해하고 이로 인해 단시간 내에 첨가된 효소가 분해되어 버리거나 실활되어 효소의 제기능을 전혀 발휘하지 못한다는 단점이 있다.By the way, the enzyme added to cosmetics for the above purpose is composed of a protein, so that its stability is extremely low, such as being easily decomposed and denatured by temperature, chemicals, etc., and thus is difficult to use. Therefore, various peripheral factors such as cosmetic composition, storage and distribution temperature of cosmetics may inhibit the stability of the enzyme and thereby decompose or deactivate the added enzyme in a short time, thereby not exhibiting any function of the enzyme. .
따라서, 이와 같은 효소의 환경적·화학적 불안정성을 제거하여 제품에 응용하는 것은 매우 중요하며, 더 나아가 제품의 제형상 및 기능상에 다양한 효과를 주어 제품의 부가가치를 높이는 기술은 화장품 산업뿐 아니라, 의약품 영역에서도 효과적으로 사용될 수 있는 중요한 기술이다.Therefore, it is very important to apply the product to the product by removing the environmental and chemical instability of the enzyme, and furthermore, the technology to increase the added value of the product by providing various effects on the formulation and function of the product is not only in the cosmetics industry, but also in the pharmaceutical field. It is an important technique that can be used effectively.
이러한 요구에 부응하여 보존 온도와 주위 조건에 따라 효소의 불안정성을제거해 주고자 하는 다양한 시도가 있어 왔다. 이중 피콜(Ficoll) 400이라는 폴리슈크로스(polysucrose)를 이용하여 효소를 안정화시키는 방법이 P.V. Sundaram 등(Protein Engineering, vol.8, no.10, 1039-1047, 1995)에 의하여 보고되었다. 이러한 방법은 심(Sim) 등(Biotechnology letter, 22:137-140, 2000)이 보고한 SC-glucan(태평양, 한국)도 P.V. Sundaram등과 유사한 방법으로 효소를 안정화하였고, 본 발명자도 이에 앞서 알터난이라는 특이적 구조를 갖는 유산균이 생산한 비이온성 다당체를 변성시켜 효소의 안정성을 높이고자 연구(대한민국 특허출원 제2001-45929호)한 바 있다. 그러나 이와같은 종래의 방법에 따른 효소의 안정화에 이용될 수 있는 다당체는 많지 않으며, 현재까지는 매우 고가인 문제점이 있었다.In response to these demands, various attempts have been made to remove enzyme instability depending on storage temperature and ambient conditions. The method of stabilizing the enzyme using a polysucrose called Ficoll 400 is P.V. Reported by Sundaram et al. (Protein Engineering, vol. 8, no. 10, 1039-1047, 1995). This method is also described by SC-glucan (Pacific, Korea) reported by Sim et al. (Biotechnology letter, 22: 137-140, 2000). The enzyme was stabilized by a method similar to that of Sundaram, and the present inventors also attempted to denature nonionic polysaccharides produced by lactic acid bacteria having a specific structure of an alternant to increase the stability of the enzyme (Korean Patent Application No. 2001-45929). I've done it. However, there are not many polysaccharides that can be used for stabilizing the enzymes according to the conventional methods, and there have been very expensive problems to date.
상술한 바와 같이, 효소를 안정화시켜 크림 및 로션 등의 화장료에서 장기간 그 안정성을 높혀서 효소활성을 장기간 유지시킬 수 있는 기술은 매우 필요하고 중요할 뿐 아니라 다당체를 이용하여 여러 특성을 갖는 효소들에 적용하고 다양한 기능성을 함께 갖춘 제품에 부가하는 것은 중요한 기술이나, 기술적 또는 경제적인 면에서 만족스러운 결과를 갖는 안정화 효소의 제조방법은 아직 제공되지 않고 있는 실정이다.As described above, a technique for stabilizing enzymes to maintain their long-term enzyme activity by increasing their stability in cosmetics such as creams and lotions is very necessary and important, and is applicable to enzymes having various properties using polysaccharides. Adding to a product with a variety of functionalities is an important technology, but the production method of the stabilizing enzyme having a satisfactory result in terms of technical or economic has not yet been provided.
한편, 종래부터 피부 미용성 화장품에 첨가되고 있는 크산탄 검 및 검 구아 검, 그리고 알지네이트는 점도 및 그 특성으로 인하여 화장료 제형의 안정성을 증가시켜주고, 피부에 도포되었을 때 피부를 코팅시켜주는 기능을 하여 피부 보습력을 향상시켜준다. 이들 다당류는 단당류의 규칙적인 직쇄상의 골격(linear backbone)과 곁가지(side chain)를 갖고 있어 이러한 다당체들을 이용하여 효소를안정화할 수 있다면, 이들 안정화된 효소가 첨가되는 제품의 제형상의 안정성은 물론 보습 기능 그리고 효소의 주요 기능인 피부 상피의 각질제거를 통한 주름살예방 및 피부상재 유해미생물의 제거 등의 기능성을 동시에 얻을 수 있다는 장점이 있는 것으로 판단된다.Meanwhile, xanthan gum, gum guar gum, and alginate, which have been conventionally added to skin cosmetics, increase the stability of cosmetic formulations due to their viscosity and properties, and have a function of coating the skin when applied to the skin. Improves skin moisturizing power. These polysaccharides have a regular linear backbone and side chains of monosaccharides, so that if these enzymes can be stabilized using these polysaccharides, the stability of the formulation of the product to which these stabilized enzymes are added Of course, the moisturizing function and the skin's epidermis, which is the main function of the enzyme, can be obtained at the same time, such as the prevention of wrinkles and the removal of harmful microorganisms on the skin.
따라서, 본 발명의 목적은 상기와 같은 종래 기술의 문제점을 해결하여, 화장품, 기능성 음료와 같은 효소의 활성 유지에 불리한 조건에서도 효소가 장기간 그 구조적 안정성을 유지할 뿐 아니라 각 효소의 특성이 제품의 제형에서 잘 나타나도록 할 수 있는 안정화 효소의 제조방법을 제공하기 위한 것이다.Accordingly, the object of the present invention is to solve the problems of the prior art as described above, so that the enzyme maintains its structural stability for a long time even under conditions that are unfavorable for maintaining the activity of enzymes such as cosmetics and functional beverages, and the characteristics of each enzyme are used in the formulation of the product. It is to provide a method for preparing a stabilizing enzyme that can be represented well in.
더욱이, 본 발명은 종래의 효소 포괄 제제(enzyme entrapping agent)보다 저가이면서도 우수한 특성을 갖는 다당체를 밝혀내어 효소 안정화 제제를 대량으로 용이하게 제조할 수 있는 방법을 제공함으로써 장기간 보관 시에도 효소의 활성이 유지되는 안정화 효소를 저렴하게 공급할 수 있는 제조방법을 제공하기 위한 것이다.In addition, the present invention is to find a polysaccharide having a lower cost and superior characteristics than a conventional enzyme entrapping agent to provide a method for easily preparing a large amount of enzyme stabilizing agent, so that the activity of the enzyme is long-term storage. An object of the present invention is to provide a manufacturing method which can supply a stabilized enzyme to be maintained at a low cost.
특히, 화장품에 첨가되는 효소를 활성유지에 불리한 환경조건이나 유통 조건 하에서도 적정하게 효소의 안정성을 유지할 수 있는 안정화 효소 함유 화장료의 제조방법을 제공하기 위한 것이다.In particular, it is an object of the present invention to provide a method for producing a stabilizing enzyme-containing cosmetic that can maintain the stability of the enzyme appropriately even under environmental conditions or circulation conditions that are disadvantageous for maintaining the enzyme added to the cosmetics.
상기와 같이 본 발명은 화장품, 기능성 음료 등에 첨가되는 효소의 안정성을 보다 용이하게 증가시킬 수 있는 방법을 제공하기 위한 것으로, 본 발명자 등은 효소와 함께 화장품, 기능성 음료 등에 첨가되는 다당체 중 특정한 다당체를 선별하여 효소 안정화에 이용될 수 있도록 알맞게 정제하여 특정한 방법으로 처리한 후 효소와 반응시킴으로서 효소의 안정성을 보다 용이하면서도 월등히 증강시킴으로서 상온에서 장기간 활성을 유지할 수 있는 안정화 효소의 제조방법을 제공하여 본 발명을 완성하였다.As described above, the present invention is to provide a method that can more easily increase the stability of the enzyme added to cosmetics, functional drinks, etc. The present inventors, such as the polysaccharide added to a specific polysaccharide added to cosmetics, functional drinks, etc. The present invention provides a method for preparing a stabilizing enzyme that can maintain long-term activity at room temperature by selecting and purifying appropriately to be used for enzyme stabilization, treating with a specific method, and then reacting with the enzyme to further enhance stability of the enzyme. Was completed.
도 1은 본 발명에 따라 제조된 안정화 효소의 분자량 증가를 확인하는 사진이고,1 is a photograph confirming the increase in molecular weight of the stabilizing enzyme prepared according to the present invention,
도 2는 본 발명에 따라 제조된 안정화 효소의 분자량 분획분별 효소화성을 나타내는 그래프이고,2 is a graph showing the molecular weight fractionation enzymaticity of the stabilizing enzyme prepared according to the present invention,
도 3은 본 발명에 따라 제조된 안정화 효소의 피부 각질 제거 활성을 나타내는 그래프이고,3 is a graph showing the skin exfoliation activity of the stabilizing enzyme prepared according to the present invention,
도 4는 본 발명에 따라 제조된 안정화 효소의 유해 미생물의 생육억제 활성을 나타내는 그래프이다.4 is a graph showing the growth inhibitory activity of harmful microorganisms of the stabilizing enzyme prepared according to the present invention.
상기한 과제를 달성하기 위해 본 발명은 효소를 안정화 하기 위한 효소 엔트랩핑(entrapping)에 있어서, 화장품 산업에서 이용되는 다당체 중 구조적으로 직쇄상의 골격(backbone)에 비교적 복잡하지 않은 곁가지(side chain) 구조를 갖는 천연 다당체를 효소 안정화에 이용될 수 있도록 알맞게 정제하여 과요오드산 나트륨(NaIO4)으로 산화하는 화학적 수식(modification)을 한 후 효소와 반응시켜 얻은 생산물을 분자량에 따라 분리·정제하여 효소가 안정화된 효소 포괄 제제를 얻음을 특징으로 한다.In order to achieve the above object, the present invention provides a relatively uncomplicated side chain in a structurally straight backbone among polysaccharides used in the cosmetic industry in enzyme entrapping for stabilizing enzymes. The natural polysaccharide having the structure is purified to be suitable for use in enzyme stabilization, chemical modification (oxidation) with sodium periodate (NaIO 4 ), and the product obtained by reacting with the enzyme is separated and purified according to the molecular weight. Is characterized by obtaining a stabilized enzyme encapsulation formulation.
상기 구성에 있어서, 효소 포괄 제제로 사용될 수 있는 다당류는 효소-다당체 간의 결합에서 효소의 활성이 나타나지 못하게 하는 다당류를 제외하고 효소의 활성을 저해시키지 않는 범위에서 효소를 안정화시킬 수 있는 다당류로서는 크산탄 검(xanthan gum), 구아 검(gum guar), 아르지네이트(alginate)등이 바람직하다.In the above constitution, a polysaccharide which can be used as an enzyme encapsulation agent is a xanthan as a polysaccharide capable of stabilizing the enzyme in a range that does not inhibit the activity of the enzyme except for a polysaccharide which prevents the enzyme activity from appearing in the enzyme-polysaccharide bond. Xanthan gum, gum guar, arginate and the like are preferred.
또한, 상기 구성에서, 효소 포괄 제제로 사용되는 다당류에 바람직하게 포괄될 수 있는 효소는 파파인(papain), 브로멜라인(bromelain), 라이소자임(lysozyme), 셀루라제(cellulase)임을 특징으로 한다.In addition, in the above configuration, the enzyme that can be preferably encompassed in the polysaccharide used as the enzyme encapsulation agent is characterized in that papain (broin), bromelain (lyezyme), cellulase (cellulase).
더욱이, 본 발명은 상기와 같이 제조된 효소 안정화 제제를 통상 효소가 첨가되는 조건으로 화장품, 기능성 음료 및 치료 또는 예방용 제제에 첨가하여 보다 장시간 효소의 활성을 지속시키는 것을 특징으로 한다.Furthermore, the present invention is characterized in that the enzyme stabilizing agent prepared as described above is added to cosmetics, functional beverages, and therapeutic or prophylactic agents under conditions to which enzymes are normally added to sustain the activity of the enzyme for a longer time.
상기와 같이 다당체와 결합된 효소는 효소가 다당체에 결합형으로 엔트랩핑되어 상온의 온도, 기타 화학 조성물등의 조건 하에서도 분해되거나 실활되지 않는다.As described above, the enzyme bound to the polysaccharide is entrapped in the form of the enzyme bound to the polysaccharide so that the enzyme is not decomposed or inactivated even under conditions such as a temperature of room temperature and other chemical compositions.
더욱이, 상기 구성에 있어서, 크산탄 검과 구아 검은 불용성 물질이 존재하기 때문에 일차적인 과요오드산 나트륨(NaIO4)과의 반응 후 일련의 침전과정으로 이를 제거시켜 수용성 다당체를 얻어 사용함이 바람직하며, 이러한 다당체를 상기 본 발명의 구성에 따라 효소와 반응시키면 효소의 안정화가 가능할 뿐만 아니라, 화장품의 점도를 유지하여 교질 안정성 향상 및 보습기능 등의 유리한 기능을 화장료에 부가할 수 있다.Furthermore, in the above configuration, since xanthan gum and guar gum are insoluble, it is preferable to remove them by a series of precipitation processes after reaction with primary sodium periodate (NaIO 4 ) to obtain a water-soluble polysaccharide, When the polysaccharide is reacted with the enzyme according to the structure of the present invention, not only the enzyme can be stabilized, but also the cosmetics can be added to cosmetics by maintaining the viscosity of the cosmetics and improving the colloidal stability and moisturizing function.
한편, 본 발명에서 단백질 분해효소(Proteolytic enzyme)인 파파인과 브로멜라인의 활성측정은 N,N-디메틸화 카세인(시그마사 제)과 Nα-벤조일-DL-알지닌-ρ-니트로아닐리드(BAPNA, 시그마사 제)를 기질로 하여 일정시간 반응 후, 스펙트로포토메터(CE 1020, 세실사 제)를 이용하여 N,N-디메틸화 카세인은 280㎚, BAPNA는 405㎚에서 흡광도를 측정하였다. 용균효소인 라이소자임은 기질로 0.1% 마이크로코커스 라이소데익티커스(Micrococcus lysodeikticus,시그마사 제)를 0.05M, pH 6.2 완충액에 분산시켜 기질과 효소액을 20:1의 비율로 효소액을 첨가하여 25℃에서 30분간 반응하고, 스펙트로포토메터를 이용하여 450㎚에서 흡광도를 측정하였다. 흡광도의 감소에 따라 효소의 활성을 측정하였다. 또 셀루라제 활성측정은기질로 카르복시메틸 셀루로스(carboxymethyl cellulose, 시그마사 제)를 0.5%되게 0.05M, pH 6.2 완충용액에 용해시키고, 효소액을 가하여 37℃에서 1시간 반응시킨 후 디니트로살리실산(DNS)법으로 정량하여 활성을 확인하였다.Meanwhile, in the present invention, the activity of papain and bromelain, which are proteolytic enzymes, is measured by N, N-dimethylated casein (Sigma) and Nα-benzoyl-DL-arginine-ρ-nitroanilide (BAPNA). After the reaction for a certain period of time using a Sigma company), absorbance was measured at 280 nm for N, N-dimethylated casein and 405 nm for BAPNA using a spectrophotometer (CE 1020, manufactured by Cecil). Lysozyme, a lytic enzyme, is dispersed as a substrate in 0.1% Micrococcus lysodeikticus ( Sigma Co. , Ltd. ) in 0.05M, pH 6.2 buffer, and the substrate and enzyme solution are added to the enzyme solution in a ratio of 20: 1 at 25 ° C. The reaction was carried out for 30 minutes, and the absorbance was measured at 450 nm using a spectrophotometer. The activity of the enzyme was measured according to the decrease in absorbance. Cellulase activity measurement was performed by dissolving carboxymethyl cellulose (Sigma) in 0.05M, pH 6.2 buffer solution to 0.5%, adding enzyme solution and reacting at 37 ° C for 1 hour, followed by dinitrosalicylic acid ( The activity was confirmed by quantification by DNS) method.
선별된 다당체를 정제하고 과요오드산 나트륨(NaIO4)으로 산화시킨 후 분리·정제하여 분자량 100K이상의 다당체를 얻어 효소와 반응시킨다. 크산탄 검과 구아 검은 많은 불용성물질을 함유하고 있으므로 과요오드산 나트륨(NaIO4)의 농도와 반응시간 등의 조건을 조절하여 이들 불용성물질을 제거하고 수용성인 부분을 얻어 효소와의 반응에 사용하여야 보다 효과적이다. 이와 같이 산화된 다당체는 효소와 쉽게 공유결합을 형성하고 효소는 다당체에 포괄되어 안정성이 증가하게 된다. 이와 같은 방법으로 얻은 효소액을 MWCO(molecular weight cut-off) 100,000(사토리우스 AG사, 독일)으로 한외여과(Ultrafiltration)하여 효소액 용량 10배의 시트레이트 완충액(0.1M, pH 6.0)으로 세척하여 MW 100,000이하의 여액은 제거하고, MW 100,000이상의 것만 회수한다. 회수된 효소포괄체의 다당체와 효소의 결합으로 인한 분자량의 증가는 SDS-PAGE 전기영동으로 확인할 수 있다. 본 발명에서 사용된 효소의 분자량은 모두 MW 50,000이하로, 파파인은 MW 약 20,700, 브로멜라인은 약 MW 33,000, 라이소자임은 약 MW 14,307, 셀루라제는 약 MW 31,000이었으므로 본 발명에 따라 처리된 효소액, 즉 다당체에 포괄되어 안정화된 효소의 분자량은 많이 증가된 것을 확인할 수가 있다. 또한 회수된 효소액의 효소활성을 반응에 첨가된 효소의 활성과 비교하면 생산수율을 감안하고 계산하여 본 결과 크산탄 검의 경우약 65%, 검 구아르 약 52%, 알지네이트 약 76% 임을 알 수 있었다.The selected polysaccharide is purified, oxidized with sodium periodate (NaIO 4 ), separated and purified, and a polysaccharide having a molecular weight of 100 K or more is reacted with an enzyme. Since xanthan gum and guar gum contain many insoluble substances, it is necessary to adjust conditions such as concentration of sodium iodide (NaIO 4 ) and reaction time to remove these insoluble substances, obtain a water-soluble part, and use it for reaction with enzyme. More effective. The oxidized polysaccharide easily forms a covalent bond with the enzyme, and the enzyme is encapsulated in the polysaccharide to increase stability. The enzyme solution obtained in this manner was ultrafiltered with MWCO (molecular weight cut-off) 100,000 (Satorius AG, Germany) and washed with citrate buffer (0.1M, pH 6.0) of 10 times the enzyme solution volume. Remove less than 100,000 filtrates and recover only MW 100,000 or more. The increase in molecular weight due to the binding of the enzyme and the polysaccharide of the recovered enzyme complex can be confirmed by SDS-PAGE electrophoresis. The molecular weight of the enzymes used in the present invention are all MW 50,000 or less, papain is MW about 20,700, bromelain is about MW 33,000, lysozyme is about MW 14,307, cellulase was about MW 31,000, the enzyme solution treated according to the present invention, That is, it can be seen that the molecular weight of the enzyme stabilized by being encapsulated in the polysaccharide was greatly increased. In addition, when comparing the enzyme activity of the recovered enzyme solution with the activity of the enzyme added to the reaction, the production yield was calculated in consideration of the yield of Xanthan gum about 65%, gum guar about 52%, alginate about 76%. there was.
이하 본 발명을 실시예와 시험예로 보다 상세히 설명하지만 본 발명이 여기에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with examples and test examples, but the present invention is not limited thereto.
실시예Example
본 실시예에서 사용하기 위하여 선별된 크산탄 검, 구아 검, 그리고 알지네이트를 25℃에서 고농도의 과요오드산 나트륨(NaIO4)과 5∼16시간동안 반응시키고, MWCO 50,000의 한외여과법으로 반응되지 않고 남은 NaIO4와 MW 50,000이하의 저분자 다당체를 제거하고, MW 50,000이상의 고분자 다당체를 분리한다. 이러한 방법으로 얻어진 다당체를 25℃에서 효소와 반응시키며, 다당체와 효소의 비율은 효소에 따라 1:2∼1:7의 비율로 첨가한다. 효소에 따라 1∼8시간 반응시킨 후 25℃에서 약 30분 동안 수소화붕소 나트륨(NaBH4)을 처리하고, 일정시간 경과후 4℃에서 장시간 두면 안정화된 효소를 얻을 수 있다.Xanthan gum, guar gum, and alginate selected for use in this example were reacted with high sodium sodium iodide (NaIO 4 ) at 25 ° C. for 5-16 hours, and not by ultrafiltration of MWCO 50,000. Remove the remaining NaIO 4 and low molecular weight polysaccharide below MW 50,000, and separate the high molecular weight polysaccharide of MW 50,000 or more. The polysaccharide obtained in this manner is reacted with the enzyme at 25 ° C., and the ratio of the polysaccharide to the enzyme is added in a ratio of 1: 2 to 1: 7 depending on the enzyme. After reacting for 1 to 8 hours depending on the enzyme, sodium borohydride (NaBH 4 ) is treated at 25 ° C. for about 30 minutes, and after a certain time, the enzyme is stabilized by leaving it at 4 ° C. for a long time.
이와 같은 방법으로 얻은 효소 다당체 반응액을 한외여과법으로 분자량 10만(MW 100,000)의 분획을 회수하므로서 다당체와 결합된 안정화 효소와 결합되지 않은 효소를 분리한다. 사용한 여러 효소는 분자량이 약 MW 20,000∼33,000이므로 분자량 10만(MW 100,000)이상의 분획을 다당체와 결합한 안정화 효소로, 그리고 분자량 10만(MW 100,000)이하의 분획을 결합되지 못한 효소라고 판단하여, 분자량 10만 이상의 분획을 화장품 제형에 사용하였고, 전기영동법(Electrophoresis; SDS-PAGE)으로 분자량의 변화를 확인하였다.The enzyme polysaccharide reaction solution obtained in this manner is separated by an ultrafiltration method to recover a fraction of molecular weight of 100,000 (MW 100,000), thereby separating the enzyme that is not bound to the stabilizing enzyme bound to the polysaccharide. Since the various enzymes used have a molecular weight of about MW 20,000 to 33,000, it is considered that the enzyme having a molecular weight of 100,000 (MW 100,000) or more is combined with a polysaccharide and the enzyme having a molecular weight of 100,000 (MW 100,000) or less is an enzyme that cannot be bound. More than 100,000 fractions were used in cosmetic formulations and the change in molecular weight was confirmed by electrophoresis (SDS-PAGE).
안정화 효소의 분자량 변화를 확인하기 위한 전기영동법(SDS-PAGE)은 아크릴아미드용액을 8% 첨가한 분리 겔(separating gel)을 사용했는데, 이는 이러한 농도에서 분자량 2만∼9만KD의 단백질을 분리할 수 있는 알맞는 영역이므로(Ref:BioMedical Research, 유욱준) 분자량이 변화된 효소는 이동이 매우 적을 것이라고 판단되기 때문이다. 4×분리 완충액(separating buffer)과 4×체류 완충액(stacking buffer)은 각각 1.5M tris-Cl(pH 8.8)과 0.5M tris-Cl(pH 6.8)을 사용하였으며, 탱크 완충액(tank buffer) 조성은 0.025M tris-Cl, 0.192M 글리신, 0.1% SDS이며, pH 8.8로 보정하였다. 또한 2×SDS 샘플 완충액의 조성은 0.125M tris-Cl(pH 6.8), 4% SDS, 20% 글리세롤, 10% 2-머캅토에탄올, 2% 브로모페놀 블루(bromophenol blue)이다. 1.5㎜ 겔(gel) 두 장에 적하(loading)하였으며, 전류 60㎃, 전압 70∼80볼트(volt)로 전기영동을 실시하였다. 도 1에 도시된 바와 같이 생산된 안정화 효소액을 전기영동(SDS-PAGE)법으로 분석한 결과 분자량의 증가를 확인할 수 있다. 본 도에서 ①, ② 및 ③은 효소와 다당체를 결합시켜 효소의 분자량이 증가된 것을 확인할 수 있는 결과이며, 이런 결과를 통하여 각 효소들이 안정화되었다는 것을 확인할 수 있다. ④는 분자량 표지물질(maker)이며, ⑤는 분자량 약 20,000 효소인 파파인이다. 이와 같은 결과로 효소와 다당체간의 결합이 이루어졌음을 확인할 수가 있다.Electrophoresis (SDS-PAGE) to confirm the molecular weight change of the stabilizing enzyme used a separating gel containing 8% of acrylamide solution, which separated the protein of 20,000-90,000 KD at this concentration. This is because an enzyme with a changed molecular weight is expected to have very little movement since it is a suitable region for this (Ref: BioMedical Research, Yu-Joon Yoo). 4 × separating buffer and 4 × stacking buffer were used with 1.5M tris-Cl (pH 8.8) and 0.5M tris-Cl (pH 6.8), respectively, and the tank buffer composition was 0.025M tris-Cl, 0.192M glycine, 0.1% SDS, calibrated to pH 8.8. The composition of the 2 × SDS sample buffer is also 0.125M tris-Cl (pH 6.8), 4% SDS, 20% glycerol, 10% 2-mercaptoethanol, 2% bromophenol blue. Two 1.5 mm gels were loaded and electrophoresed with a current of 60 mA and a voltage of 70 to 80 volts. As shown in FIG. 1, the stabilizing enzyme solution produced was analyzed by electrophoresis (SDS-PAGE) to confirm the increase in molecular weight. ①, ② and ③ in this figure is a result that can confirm that the molecular weight of the enzyme is increased by combining the enzyme and the polysaccharide, it can be confirmed that each enzyme is stabilized through this result. ④ is the molecular weight marker (maker), ⑤ is papain with a molecular weight of about 20,000 enzymes. As a result, the binding between the enzyme and the polysaccharide can be confirmed.
<시험예 1><Test Example 1>
안정화 효소의 활성 시험Stabilization Enzyme Activity Test
효소와 다당체간의 결합으로 생산되는 물질의 분자량의 변화는 효소의 반응속도 및 모든 역학적 관계에 영향을 미친다. 상기 실시예에 따라 생산된 안정화 효소의 대략적인 분자량을 확인하기 위하여 다음과 같은 실험을 실시하였다. 먼저 MWCO 100,000 한외여과법으로 분자량 10만 이상의 분획과 분자량 100,000 이하의 분획을 분리하였다. 이때 2배 이상의 0.1M pH 6.0 시트레이트 완충액(citrate buffer)으로 세척하였으며, 분자량 10만 이하의 분획을 하고, 이 분획을 다시 MWCO 50,000 한외여과법으로 분자량 5만 이상 10이하와 5만 이하의 분획분으로 분해하였다. 그리고, 각 분획분의 효소활성을 조사하여 얻어진 효소-다당체의 분자량을 확인하였으며, 그 결과는 도 2와 같다.Changes in the molecular weight of the material produced by the bond between the enzyme and the polysaccharide affect the reaction rate and all mechanical relationships of the enzyme. In order to confirm the approximate molecular weight of the stabilizing enzyme produced according to the above example, the following experiment was performed. First, a fraction of 100,000 or more molecular weight and a fraction of 100,000 or less molecular weight were separated by MWCO 100,000 ultrafiltration. At this time, two or more times 0.1M pH 6.0 citrate buffer (citrate buffer), and washed with a fraction of less than 100,000 molecular weight, this fraction was again fractional fraction of 50,000 or more and less than 10 and less than 50,000 by MWCO 50,000 ultrafiltration. To decompose. In addition, the molecular weight of the enzyme-polysaccharide obtained by investigating the enzymatic activity of each fraction was as shown in FIG.
라이소자임을 제외하고 파파인과 브로멜라인, 셀루라제는 분자량 10만 이상의 분획에서 대부분의 활성이 나타나는 것을 확인할 수 있었다. 이것은 다당체의 NaIO4처리 후 분자량 5만 이하의 다당체를 제거하였으므로 효소와 다당체간의 결합이 효율적으로 이루어졌다는 것을 의미하는 것이다. 따라서 효소의 안정화가 효율적으로 이루어졌다고 판단할 수 있다. 그러나 라이소자임의 경우에서는 분자량 5만 이상 10만 이하의 분획에서도 높은 효소활성을 나타내었다. 이는 라이소자임의 분자량이 매우 낮은(약 MW 14,407) 것에서 기인된 것이나 전기영동법에 의한 분석에서도 볼 수 있듯이 효소의 대부분이 다당체와 결합된 것으로 판단된다.Except for lysozyme, papain, bromelain, and cellulase were found to have the most activity in the fractions of 100,000 or more. This means that after the NaIO 4 treatment of the polysaccharide, the polysaccharide having a molecular weight of 50,000 or less was removed, so that the binding between the enzyme and the polysaccharide was efficiently performed. Therefore, it can be judged that the stabilization of the enzyme was performed efficiently. However, lysozyme showed high enzymatic activity even in fractions of 50,000 to 100,000. This is due to the very low molecular weight of the lysozyme (about MW 14,407), but as can be seen by the electrophoresis analysis, it seems that most of the enzyme is combined with the polysaccharide.
<시험예 2><Test Example 2>
안정화 효소에 의한 피부 각질 제거 시험Skin exfoliation test by stabilizing enzyme
디하이드록시아세톤법(Dihydroxyacetine, G.E.Pierard, Dermatology, 186, 133∼137, 1993)을 사용하여 안정화 효소에 의한 피부 각질 제거 시험을 하였다.디하이드록시아세톤법은 10%농도로 디하이드록시아세톤을 크림제형에 첨가하여 피부에 도포하면 피부 각질의 단백질과 디하이드록시아세톤은 매일라드(maillard) 반응을 일으켜 도포된 부위의 피부는 흑갈색으로 변한다. 이렇게 검게된 피부는 각질이 제거됨에 따라 점차 색이 엷어지다가 없어지게 되는데 이러한 주기는 약 7∼10일로 본래의 피부와 같아진다. 그러나 효소를 도포하면 그 주기를 단축시킬 수 있다. 따라서 화장품의 제형상에서 안정화된 효소의 활성을 나타내는 지 육안으로 확인할 수 있는 것이다. 디하이드록시아세톤 도포 1일 경과 후부터 1일 2회 도포하여 각질을 제거하였으며, 1회 도포시 효소작용시간은 10분이었다.The dehydroxyacetone method (Dihydroxyacetine, GEPierard, Dermatology, 186, 133-137, 1993) was used to perform skin exfoliation test by stabilizing enzyme. The dihydroxyacetone method was used to remove dihydroxyacetone at a concentration of 10%. When added to the cream formulation and applied to the skin, keratin protein and dihydroxyacetone cause a maillard reaction, turning the skin to a dark brown color. This blackened skin becomes thinner and fades away as keratin is removed. This cycle is about 7-10 days, the same as the original skin. However, application of enzymes can shorten the cycle. Therefore, it can be confirmed by the naked eye to show the activity of the stabilized enzyme in the cosmetic formulation. Corneal was removed by applying twice a day from 1 day after the application of dihydroxy acetone, and the enzyme action time was 10 minutes.
생산된 효소가 화장품 제형상에서 그 활성을 유지할 수 있는가에 관한 실험을 하기 위하여 로션제형에 각 안정화 효소를 첨가하여 각질제거 효능을 비교한 것을 그레이 레벨(gray level)로 나타내었다. 실험에 사용된 효소는 파파인과 라이소자임 그리고 셀루라제가 이용되었으며, 각질 제거능을 수치화하기 위하여 스킨 비지오미터(Skin Visiometer) SV600(CK electronics GmbH, Germany)와 시그마스캔 프로(Sif\gmascan pro) 3.0(Sigma Co. Ltd)을 이용하였으며, 그레이 레벨을 측정한 결과가 도 3과 같이 나타났다.In order to test whether the produced enzyme can maintain its activity on the cosmetic formulation, the comparison of the exfoliation efficacy by adding each stabilizing enzyme to the lotion formulation is shown in gray level. The enzymes used in the experiments were papain, lysozyme and cellulase. Skin Visiometer SV600 (CK electronics GmbH, Germany) and Sif\gmascan pro 3.0 (Sigma) were used to quantify the exfoliation capacity. Co. Ltd), and the gray level was measured as shown in FIG. 3.
도면에서 볼 수 있듯이 안정화 효소 첨가군의 색이 대조군에 비하여 더 엷어졌기에 그레이 레벨로 분석하였을 때 안정화 효소 첨가군의 곡선이 오른쪽, 즉 백색 방향으로 치우친 것을 볼 수 있었다. 따라서 안정화 효소 첨가군이 보다 빠른 속도로 각질을 제거한다는 것을 확인할 수 있었으며, 화장품 제형에서 안정하게 각질제거능을 나타낼 수 있다는 것을 확인할 수 있었다.As shown in the figure, the color of the stabilizing enzyme-added group was thinner than the control group, and when analyzed with gray level, the curve of the stabilizing enzyme-added group was shifted to the right, that is, the white direction. Therefore, it was confirmed that the stabilizing enzyme-added group removes keratin at a faster rate, and it can be confirmed that the cosmetic formulation can stably exhibit exfoliation ability.
파파인과 같은 프로테아제의 경우는 피부표면의 단백질을 분해하여 각질을 제거시킨다는 것은 여러 보고가 있었는 바이며, 라이소자임의 경우는 난백유래의 용균효소의 특성에서 주어지는 각질 제거능과 비교적 높은 역가의 효소를 처리한 것에서 높은 각질 제거능이 나타난 것이다. 또한 셀루라제의 경우는 비교적 적은 각질 제거능을 갖고 있으나 셀루라제의 경우는 피부에 존재하는 유해세균의 생육을 제어할 수 있는 기능을 갖기에 유용하게 이용될 수 있다고 판단한다.Protease, such as papain, has been reported to remove keratin by breaking down proteins on the surface of the skin, and lysozyme was treated with enzymes with high titer removal ability and relatively high titer given by the characteristics of lytic enzymes derived from egg whites. High exfoliation ability in the In addition, the cellulase has relatively little exfoliation ability, but the cellulase may be usefully used to have a function of controlling the growth of harmful bacteria present in the skin.
<시험예 3><Test Example 3>
유해세균 억제력 측정Hazardous bacteria inhibition
이론적으로 라이소자임은 용균효소로서 N-아세틸 헥소스아미다제 활성으로 피부에 존재하는 유해세균의 세포벽에 존재하는 펩티도글리칸(peptidoglycan)을 분해시킴으로 유해세균의 생육을 억제할 수 있는 능력을 갖고 있으며, 프로테아제인 파파인 역시 세균 세포벽의 펩티도글리칸의 펩티드결합을 분해시킴으로 세균의 생육을 억제할 수 있다(효소학, 정동효, 1993, 선진문화사). 이에 착안하여 라이소자임과 파파인을 안정화시킨 후 피부에 존재하는 유해세균인 스타필로코커스 아우레우스(Staphylococcus aureus)와 프로피오니박테리움 에이크네스(Propionibacterium acnes), 그리고 유해균은 아니지만 진균억제력을 측정하기 위하여 사카로마이세스 세레비지에(Sacchaomyces serevisiae) 3종의 미생물의 생육억제력을 시험하였다.In theory, lysozyme is a lytic enzyme that has the ability to inhibit the growth of harmful bacteria by decomposing peptidoglycans on the cell walls of harmful bacteria present in the skin with N-acetyl hexosamidase activity. Papain, a protease, can also inhibit the growth of bacteria by degrading the peptide bonds of peptidoglycans on the bacterial cell wall (enzymatics, Chung Dong-hyo, 1993, Advanced Culture History). In this regard, staphylococcus aureus and propionibacterium acnes , which are harmful bacteria present in the skin after stabilizing lysozyme and papain, and sacca to measure fungal inhibitory activity, although not harmful bacteria Sacchaomyces serevisiae was tested for growth inhibition of three microorganisms.
세균의 경우는 Brain Heart Infusion medium(Difco Co. Ltd.)으로 배양하였고, 진균인 효모는 Malt extrat medium(Difco Co. Ltd.)으로 배양하였으며, 미생물의 접종 미생물의 농도는 3%로 정하여 시험하였다. 안정화 효소의 미생물생육 억제력 시험에 사용하기 위하여 살균된 0.2㎛ 필터(Minisart plus, 사토리우스사 제, 독일)로 제균하였으며, 5% 농도로 배지에 첨가되어 시험하였다. 대조구로는 효소액을 대신하여 폴리머(polymer)를 같은 비율로 첨가하여 미생물을 접종한 후 동일한 조건에서 배양하였다. 미생물의 배양온도는 스타필로코커스 아우레우스(Staphylococcus aureus)와 프로피오니박테리움 에이크네스(Propionibacterium acnes)는 37℃에서 혐기적으로 배양하였으며, 사카로마이세스 세레비지에(Sacchaomyces serevisiae)는 30℃에서 혐기적으로 배양하였고, 3종의 미생물을 24시간 동안 배양동안 배양한 후 스펙트로포토메터(CE 1020, Cecil Co. Ltd.)를 이용하여 620㎚에서 흡광도를 측정하였다. 그 결과는 도 4와 같다.Bacteria were cultured with Brain Heart Infusion medium (Difco Co. Ltd.), yeasts with fungi were cultured with Malt extrat medium (Difco Co. Ltd.), and the concentration of microorganisms was tested at 3%. . For use in the microbial growth inhibition test of the stabilizing enzyme was sterilized with a sterilized 0.2 ㎛ filter (Minisart plus, manufactured by Sartorius, Germany) and added to the medium at 5% concentration and tested. As a control, a polymer was added in the same ratio in place of the enzyme solution to inoculate microorganisms and then cultured under the same conditions. Microorganisms were cultured anaerobicly at 37 ° C for Staphylococcus aureus and Propionibacterium acnes, and at 30 ° C for Sacchaomyces serevisiae. After anaerobic culture, three microorganisms were cultured for 24 hours, and then absorbance was measured at 620 nm using a spectrophotometer (CE 1020, Cecil Co. Ltd.). The result is shown in FIG. 4.
도 4의 결과는 안정화된 효소 라이소자임과 파파인은 피부에 존재하는 유해 미생물인 스타필로코커스 아우레우스(Staphylococcus aureus)와 프로피오니박테리움 에이크네스(Propionibacterium acnes)그리고 사카로마이세스 세레비지에(Sacchaomyces serevisiae)의 생육을 억제할 수 있다는 것을 나타낸다. 각 효소와 미생물에 따라 다소 차이가 있으나 최소 약 12%로부터 최대 약 45%까지 미생물의 생육을 억제한다. 따라서 효소를 안정화하여 화장품에 사용하였을 때 화장품의 사용으로 피부 유해세균을 억제할 수 있으며, 피부의 트러블 감소 및 여드름 예방효과를 예상할 수 있는 것이다.Results in Figure 4 is stabilized enzyme lysozyme and papain are microorganisms Stein present in the skin Philo aureus (Staphylococcus aureus) and propionyl sludge tumefaciens acre Ness (Propionibacterium acnes) and in my process serenity busy with saccharide (Sacchaomyces serevisiae ) can be suppressed. Although slightly different for each enzyme and microorganism, the growth of microorganisms is suppressed from at least about 12% to up to about 45%. Therefore, when used in cosmetics by stabilizing the enzymes can be used to suppress harmful bacteria of the skin, it can be expected to reduce the skin trouble and prevent acne.
상기 구성에 따른 본 발명은 온도 등의 조건 및 화학적인 조건에 따라 매우 불안정한 효소단백질을 용이하게 안정화시킬 수 있는 기술로서 크산탄 검 및 구아 검 그리고 알지네이트를 사용하여 효소를 용이하게 엔트랩핑시킴으로 다당체 자체의 우수한 특성을 유지하면서 효소단백질을 안정화시켜 제품에 사용할 수 있도록 하는 유용한 방법이다. 특히, 본 발명은 현재 화장품 및 의약품 산업에서 사용되고 있는 다당체를 이용하여 부가적인 기능성을 부가할 수 있을 뿐 아니라 효소의 활성이 제형에서 지속적으로 장기간 유지시킬 수 있어 우수한 화장품 산업 및 의약품 산업에서도 유용하게 사용될 수 있는 유용한 발명이다.The present invention according to the above constitution is a technology that can easily stabilize a very unstable enzyme protein according to conditions such as temperature and chemical conditions, polysaccharide itself by easily encapsulating the enzyme using xanthan gum, guar gum and alginate It is a useful method to stabilize the enzyme protein while maintaining the excellent properties of the so that it can be used in the product. In particular, the present invention can not only add additional functionality by using polysaccharides currently used in the cosmetic and pharmaceutical industries, but also be useful in the cosmetic and pharmaceutical industries because the activity of the enzyme can be continuously maintained in the formulation for a long time. It is a useful invention that can be.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010084980A KR20030055442A (en) | 2001-12-26 | 2001-12-26 | Stabilized enzyme producing method using a polymer and a composition contained these enzyme |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020010084980A KR20030055442A (en) | 2001-12-26 | 2001-12-26 | Stabilized enzyme producing method using a polymer and a composition contained these enzyme |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20030055442A true KR20030055442A (en) | 2003-07-04 |
Family
ID=32213362
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020010084980A KR20030055442A (en) | 2001-12-26 | 2001-12-26 | Stabilized enzyme producing method using a polymer and a composition contained these enzyme |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20030055442A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011086293A1 (en) | 2009-12-22 | 2011-07-21 | Institut National De La Recherche Agronomique - Inra | Sulfatase selectively modifying glycosaminoglycans |
US11382958B2 (en) | 2016-01-31 | 2022-07-12 | Mediwound Ltd. | Debriding composition for treating wounds |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198353A (en) * | 1988-02-11 | 1993-03-30 | Novo Nordisk A/S | Method for preparing stabilized enzyme dispersion |
KR20000006528A (en) * | 1998-06-29 | 2000-01-25 | 프리돌린 클라우스너, 롤란드 비. 보레르 | Phytase formulation |
KR20000060771A (en) * | 1999-03-19 | 2000-10-16 | 서경배 | A method for stabilizing enzymes or proteins and compositions for external application containing enzymes or proteins stabilized thereby |
KR20010037633A (en) * | 1999-10-19 | 2001-05-15 | 손경식 | Method and composition for increasing stability and activity of enzymes |
-
2001
- 2001-12-26 KR KR1020010084980A patent/KR20030055442A/en not_active Application Discontinuation
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5198353A (en) * | 1988-02-11 | 1993-03-30 | Novo Nordisk A/S | Method for preparing stabilized enzyme dispersion |
KR20000006528A (en) * | 1998-06-29 | 2000-01-25 | 프리돌린 클라우스너, 롤란드 비. 보레르 | Phytase formulation |
KR20000060771A (en) * | 1999-03-19 | 2000-10-16 | 서경배 | A method for stabilizing enzymes or proteins and compositions for external application containing enzymes or proteins stabilized thereby |
KR20010037633A (en) * | 1999-10-19 | 2001-05-15 | 손경식 | Method and composition for increasing stability and activity of enzymes |
Non-Patent Citations (1)
Title |
---|
Protein Eng. 1995 Oct;8(10):1039-47, Rajalakshmi N * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011086293A1 (en) | 2009-12-22 | 2011-07-21 | Institut National De La Recherche Agronomique - Inra | Sulfatase selectively modifying glycosaminoglycans |
US11382958B2 (en) | 2016-01-31 | 2022-07-12 | Mediwound Ltd. | Debriding composition for treating wounds |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0845972B1 (en) | Use of mutated subtilisin protease in cosmetic products | |
DE69225888T2 (en) | CATALASES, THEIR PRODUCTION AND USE | |
JP4077126B2 (en) | Denatured protein, method for producing the same, and external preparation composition containing the denatured protein | |
EP1125583A1 (en) | Use of compatible solutes as inhibitors of the enzymatic degradation of macromolecular biopolymers | |
JP2000514288A (en) | Recombinant enzyme having mutanase activity | |
KR20030055442A (en) | Stabilized enzyme producing method using a polymer and a composition contained these enzyme | |
Ngo et al. | Purification of endopolygalacturonase from submerged culture of Aspergillus awamori L1 using a two-step procedure: Enzyme precipitation and gel filtration | |
US4576914A (en) | Method for enhancing a fungus-lytic activity of β-1,3-D-glucanase | |
US7943354B2 (en) | Method to remove bisulfite by-products from enzyme compositions | |
WO2001011969A1 (en) | ENZYMATIC METHOD FOR KILLING OR INHIBITING MICROBIAL CELLS AT HIGH pH | |
Zhe-fu et al. | Chitinases from seeds of Zea mays and Coix lachryma-jobi L. Purification and some properties | |
US5395613A (en) | Process for degradation of keratin, keratinaceous material, collagen and collagenaceous material with enzyme material, cell-free culture or cell culture from micrococcus sedentarius | |
KR100329962B1 (en) | a protease which degrades keratin layers of skin surface, a microorganism which produces the protease and a cosmetic composition containing a culture solution thereof. | |
AU726185B2 (en) | Product for the protein stabilization of wines | |
KR100346177B1 (en) | Method and composition for increasing stability and activity of enzymes | |
DE69807712T2 (en) | ORAL HYGIENE COMPOSITION, CONTAINING A BACTERIAL PULLULANASE AND DEXTRANASE | |
KR100447055B1 (en) | Technical procedure of modified Alternan production and enzyme stabilization | |
KR100427638B1 (en) | The compositons of enzyme complex which enhance enzyme stability and the cosmetic product containing the complex | |
Nasiri et al. | Purification of a Moderately Thermal Stable Amylase from Earthworm Allolobophora Choloretica for Starch Processing | |
KR960016189B1 (en) | Cosmetics containing capsules comprising stabilized enzyme | |
KR20230080556A (en) | Colostrum hydrolysis product and skin improvement composition containing it | |
CN114209819A (en) | Production process of liposome-encapsulated protease | |
CH631484A5 (en) | METHOD FOR PRODUCING PROTEINS AND PEPTIDE-DEGRADING ENZYMES. | |
Arteaga et al. | Tetrathionate protects proteolytic activity of simulated papaya latex and crude papain | |
CN113546020A (en) | Preparation method of grape wine mud mask and grape wine mud mask |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |